Mutations Leu427, Asn428, and Leu431 residues within transmembrane domain-I-segment 6 attenuate ginsenoside-mediated L-type Ca(2+) channel current inhibitions.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Biological and Pharmaceutical Bulletin

• Publication date

  2009-07-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1248/BPB.32.1224PMID 19571390
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ginsenoside Rg3 Inhibits Human Kv1.4 Channel Currents by Interacting with the Lys531 Residue

  2008cited by this paper
• Cav1 L‐type Ca2+ channel signaling complexes in neurons

  2008cited by this paper
• Involvement of batrachotoxin binding sites in ginsenoside-mediated voltage-gated Na+ channel regulation.

  2008cited by this paper
• Calcium channel antagonists: clinical uses--past, present and future.

  2007cited by this paper
• Mutations of arginine 222 in pre-transmembrane domain I of mouse 5-HT(3A) receptor abolish 20(R)- but not 20(S)-ginsenoside Rg(3) inhibition of 5-HT-mediated ion currents.

  2007cited by this paper
• Ginsenosides: are any of them candidates for drugs acting on the central nervous system?

  2007cited by this paper
• Effects of ginsenosides and their metabolites on voltage-dependent Ca(2+) channel subtypes.

  2006cited by this paper
• Stereospecificity of ginsenoside Rg3 action on ion channels.

  2004cited by this paper
• Key roles of Phe1112 and Ser1115 in the pore-forming IIIS5-S6 linker of L-type Ca2+ channel alpha1C subunit (CaV 1.2) in binding of dihydropyridines and action of Ca2+ channel agonists.

  2003cited by this paper
• Ginseng and ginsenoside Rg3, a newly identified active ingredient of ginseng, modulate Ca2+ channel currents in rat sensory neurons.

  2002cited by this paper
• beta-Subunits: fine tuning of Ca(2+) channel block.

  2002cited by this paper
• Effect of ginsenosides on voltage-dependent Ca(2+) channel subtypes in bovine chromaffin cells.

  2001cited by this paper
• On the Role of Ca2+- and Voltage-Dependent Inactivation in Cav1.2 Sensitivity for the Phenylalkylamine (-)Gallopamil

  2001cited by this paper
• Rocking and rolling with Ca2+ channels.

  2001cited by this paper
• Inactivation determinant in the I‐II loop of the Ca2+ channel α1‐subunit and β‐subunit interaction affect sensitivity for the phenylalkylamine (−)gallopamil

  1999cited by this paper
• Effects of ginsenosides on myocardial reperfusion arrhythmia and lipid superoxidation in high cholesterol diet rats.

  1999cited by this paper
• Molecular Mechanism of Diltiazem Interaction with L-type Ca2+ Channels*

  1998cited by this paper
• Motif III S5 of L-type Calcium Channels Is Involved in the Dihydropyridine Binding Site

  1997cited by this paper
• Panax ginseng pharmacology: a nitric oxide link?

  1997cited by this paper
• Analysis of the Dihydropyridine Receptor Site ofl-type Calcium Channels by Alanine-scanning Mutagenesis*

  1997cited by this paper
• Ion Channels in Excitable Membranes

  1996cited by this paper
• A trace component of ginseng that inhibits Ca2+ channels through a pertussis toxin-sensitive G protein.

  1995cited by this paper
• Ginseng root extract inhibits calcium channels in rat sensory neurons through a similar path, but different receptor, as mu-type opioids.

  1994cited by this paper
• [Effect of panaxatriol saponins isolated from Panax notoginseng (PTS) on myocardial ischemic arrhythmia in mice and rats].

  1992cited by this paper
• Dual action (stimulation, inhibition) of D600 on contractility and calcium channels in guinea‐pig and cat heart cells.

  1989cited by this paper

• Target Cell Extraction and Spectrum–Effect Relationship Coupled with BP Neural Network Classification for Screening Potential Bioactive Components in Ginseng Extract with a Protective Effect against Myocardial Damage

  2024cites this paper
• Functional compounds of ginseng and ginseng-containing medicine for treating cardiovascular diseases

  2022cites this paper
• Ginsenosides for Cardiovascular Diseases; Update on Pre-clinical and Clinical Evidence, Pharmacological Effects and the Mechanisms of Action.

  2021cites this paper
• Chemical constituents of Panax ginseng and Panax notoginseng explain why they differ in therapeutic efficacy.

  2020cites this paper
• Korean red ginseng excitation of paraventricular nucleus neurons via non-N-methyl-D-aspartate glutamate receptor activation in mice

  2018cites this paper
• Pharmacological and medical applications of Panax ginseng and ginsenosides: a review for use in cardiovascular diseases

  2017cites this paper
• Molecular Basis of Altered hERG1 Channel Gating Induced by Ginsenoside Rg3

  2017cites this paper
• State-dependent inter-repeat contacts of exceptionally conserved asparagines in the inner helices of sodium and calcium channels

  2015cites this paper
• Ginseng pharmacology: a new paradigm based on gintonin-lysophosphatidic acid receptor interactions

  2015cites this paper
• Ginseng ginsenoside pharmacology in the nervous system: involvement in the regulation of ion channels and receptors

  2014influential citation
• Ginseng Gintonin Activates the Human Cardiac Delayed Rectifier K+ Channel: Involvement of Ca2+/Calmodulin Binding Sites

  2014cites this paper
• Yin and Yang of ginseng pharmacology: ginsenosides vs gintonin

  2013cites this paper
• Effects of Protopanaxatriol-Ginsenoside Metabolites on Rat N-Methyl-D-Aspartic Acid Receptor-Mediated Ion Currents

  2012cites this paper
• Roles and mechanisms of ginseng in protecting heart

  2012cites this paper
• Cardiovascular Diseases and Panax ginseng: A Review on Molecular Mechanisms and Medical Applications

  2012cites this paper
• Ginsenoside Rg3 enhances large conductance Ca2+-activated potassium channel currents: A role of Tyr360 residue

  2011cites this paper
• Ginsenoside Rg(3) decelerates hERG K(+) channel deactivation through Ser631 residue interaction.

  2011cites this paper
• Ginsenoside Rg3 activates human KCNQ1 K+ channel currents through interacting with the K318 and V319 residues: a role of KCNE1 subunit.

  2010cites this paper